INS and obesity disorder: In rodents and humans with obesity and insulin resistance, elevated expression and downstream signaling of TLR4 has been demonstrated in insulin-target tissues (muscle, liver and adipose tissue) [2–4] and immune cells (monocytes and macrophages) [5, 6].